ライフサイエンスコーパス: unconfirmed

1 , 223 (3%) were HIV positive (including five unconfirmed).

2 82% (55% complete response/complete response-unconfirmed).

3 ty is likely involved, yet relationships are unconfirmed.

4 substrate import and product export is still unconfirmed.

5 ndrial changes in apoptosis in flies remains unconfirmed.

6 costeroids for treatment of bronchiolitis is unconfirmed.

7 tive impairment, depression, and anxiety are unconfirmed.

8 n in supporting cellular photosensitivity is unconfirmed.

9 ective pH gradient at the gastric surface is unconfirmed.

10 tamine (HT)4, has been suggested but remains unconfirmed.

11 nsability and evolutionary rate has remained unconfirmed.

12 sumptions remain imprecise, unchallenged, or unconfirmed.

13 with active tuberculosis, infection is often unconfirmed.

14 The mediator(s) of TGF remains unconfirmed.

15 e is representative of the total response is unconfirmed.

16 association between the 2 disorders is still unconfirmed.

17 proved technically difficult, and it remains unconfirmed.

18 ambiguous results, and these cases remained unconfirmed.

19 specific susceptibility loci are unknown or unconfirmed.

20 ence interval, 27% to 63%), but this remains unconfirmed.

21 ut the molecular basis of this shift remains unconfirmed.

22 though due to its weak absorption it remains unconfirmed.

23 rprint of Earth's core in the mantle remains unconfirmed.

24 However, other associations remain unconfirmed.

25 episodic oceanic oxygenation events, remain unconfirmed.

26 of long-term cardiovascular disease remains unconfirmed.

27 tend to have metastatic disease, but this is unconfirmed.

28 enin-angiotensin-dependent functions remains unconfirmed.

29 induced salt loss, but this function remains unconfirmed.

30 they are not needed, remains experimentally unconfirmed.

31 good surrogate for other dimensions remains unconfirmed.

32 tance as a risk factor for mortality remains unconfirmed.

33 care for patients but this potential remains unconfirmed.

34 their existence in dinoflagellates remained unconfirmed.

35 eved a clinical complete response (CR) or CR unconfirmed.

36 ch frequency was lower for participants with unconfirmed (0.6%; 95% CrI, 0.1%-1.3%; I2 = 54.3%) than

37 0%, 14 complete remission/complete remission unconfirmed, 10 partial response) patients, including 17

38 tity/characteristics of such a gene(s) still unconfirmed, a lack of inactivating structural mutations

39 nalysis of variance F value=5.6, P=.001) was unconfirmed after clinical characteristic adjustment (AN

40 ved complete remission or complete remission unconfirmed after first-line rituximab plus cyclophospha

41 %) with ROS1-positive NSCLC; one patient had unconfirmed ALK and ROS1 status.

42 ad confirmed partial responses (15.0% (6/40) unconfirmed), all at DLs >=2.4 mg kg(-1).

43 sponsible for most sporadic epidemics remain unconfirmed, although attenuated vaccines that retain a

44 rombosis in patients with advanced cancer is unconfirmed and it is unknown whether current internatio

45 enzymes, deoxyribonuclease (DNase), remains unconfirmed and not studied in invadosomes.

46 on the efficacy front, with only a few still unconfirmed and potential positive trends.

47 ed for routine cyclophosphamide treatment is unconfirmed and requires further study.

48 he main limitation, with a majority of cases unconfirmed and the proportion of true diphtheria cases

49 (complete plus partial response) was 38.6% (unconfirmed) and 28.1% (confirmed) per irRECIST.

50 se; six (29%) had a complete response (three unconfirmed) and five (24%) had a partial response (one

51 patients experienced partial responses (one unconfirmed), and 56% of mCRPC patients achieved >=50% r

52 7% complete response, 6.7% complete response unconfirmed, and 40% partial response).

53 er the intermediate pressure, finally to an "unconfirmed" antiferromagnetic structure under the high

54 s provide spectroscopic evidence for two yet unconfirmed As(III)-NOM interaction mechanisms, which ma

55 Furthermore, CNSL diagnosis often remains unconfirmed because of contraindications for invasive st

56 clitaxel was associated with more favourable unconfirmed best overall response rate (63% versus 55% w

57 s sensing mechanical forces in podocytes are unconfirmed, but the classic transient receptor potentia

58 Though unconfirmed by NMR, our data suggest that the formation

59 than in more than 24,000 neuropathologically unconfirmed cases and controls.

60 nsitivity analyses of the true HIV status of unconfirmed cases and test sensitivity resulted in a pos

61 Among 88 unconfirmed cases, reference testing was available for 6

62 ncluding 21 (4.9%) Confirmed and 133 (30.9%) Unconfirmed cases.

63 g 17/21 (81.0%) Confirmed and 38/133 (28.6%) Unconfirmed cases.

64 to myelodysplastic syndrome, and one with an unconfirmed cause).

65 genesis, others suggest likely but presently unconfirmed causes.

66 n additional nine of eleven patients who had unconfirmed clinical TB and whose symptoms improved whil

67 y more tumor cells stained HER2+ than in the unconfirmed cohort, and the HER2 amplification ratio was

68 ll response rate, site-reported confirmed or unconfirmed complete or partial response.

69 ts (49%) achieving either a complete (CR) or unconfirmed complete remission [CR(u)] and 11 patients (

70 Complete remission and unconfirmed complete remission after first-line treatmen

71 erapy to ECFI patients in complete remission/unconfirmed complete remission.

72 re as follows: 1 complete response (1.9%), 3 unconfirmed complete response (5.7%), 3 partial response

73 end point was the rate of complete response/unconfirmed complete response (CR/CRu) as assessed by an

74 iscontinuation, no complete response (CR) or unconfirmed complete response (CRu) after eight cycles,

75 If complete response (CR) or unconfirmed complete response (CRu) without evidence for

76 o received pixantrone achieved a complete or unconfirmed complete response at end of treatment compar

77 00%) with complete response (CR) in 9 (41%), unconfirmed complete response in 1 (5%), and partial res

78 he proportion of patients with a complete or unconfirmed complete response in the intention-to-treat

79 sponse rate was 82% (complete response, 50%; unconfirmed complete response, 5%; partial response, 26%

80 onse rate of 77% (15% complete response, 19% unconfirmed complete response, and 43% partial) was obse

81 l response (ie, confirmed complete response, unconfirmed complete response, and partial response) at

82 of patients achieved a complete response or unconfirmed complete response.

83 s, including a 12% rate of complete response/unconfirmed complete response.

84 representative patient cohort, complete and unconfirmed complete responses after rituximab chemother

85 Non-pathogenic, unconfirmed copy number calls were detected by both plat

86 mortality, likely reflecting mortality among unconfirmed COVID-19 cases.

87 r death in people with suspected, but mostly unconfirmed COVID-19.

88 Primary end point was complete response (CR)/unconfirmed CR (CRu) rate at 6 months.

89 s 58%, with one complete remission (CR), one unconfirmed CR (CRu), and four partial remissions (PR) a

90 ge III or IV FL with complete response (CR), unconfirmed CR (CRu), or partial response (PR) after fir

91 ne were assessed for complete response (CR), unconfirmed CR (CRu), partial response (PR), stable dise

92 An additional 4% achieved an unconfirmed CR in each group.

93 The complete response (CR)/unconfirmed CR rate was 85% in 189 evaluable patients, 9

94 3), including a 7% complete response (CR) or unconfirmed CR rate.

95 (90.8%) and 13 with B-LL (76.5%) reached CR/unconfirmed CR, including 26 with T-LL and two with B-LL

96 complete response [CR], n = 18; undocumented/unconfirmed CR, n = 6; partial response, n = 14).

97 was 33% including 8% complete response (CR)/unconfirmed CR.

98 and 87% achieved a complete response (CR) or unconfirmed CR.

99 patients in first complete remission (CR) or unconfirmed CR.

100 ieving a complete response/complete response unconfirmed (CR/CRu) to CVP and making an anti-idiotype

101 es by NHL-CT criteria included three CRs, 12 unconfirmed CRs (CRus), 16 PRs, 26 with SD, four with PD

102 including 67% complete remissions (CRs plus unconfirmed CRs [CRu's]) and 23% partial remissions (PRs

103 of 15 (60%) with complete responses (CRs and unconfirmed CRs).

104 atients achieved a complete response (CR)/CR unconfirmed (CRu), and 48% of patients obtained a partia

105 Complete (CR), CR unconfirmed (CRu), and partial response (PR) rates were

106 was 100% with 86% complete response (CR)/CR unconfirmed (CRu; n = 35).

107 , ORR was 49% (14% complete response [CR]/CR unconfirmed [CRu]), median TTP was 7.0 months, and media

108 ere considered "cases", and all confirmed or unconfirmed deceased as "deaths".

109 inal decarboxylation, and the two previously unconfirmed dehydroalanines.

110 The role of respiratory SCs remains largely unconfirmed despite evidence supporting their necessity

111 d patients were assessable (two patients had unconfirmed diagnoses).

112 tients treated for TB have microbiologically unconfirmed diagnoses.

113 ain radiography) diagnostic study or with an unconfirmed diagnosis of herniated nucleus pulposus, out

114 rt comprised 31% female; 40% with RA and 16% unconfirmed diagnosis.

115 identified multiple previously unreported or unconfirmed disease associations, including known CD loc

116 nsus case definitions for both Confirmed and Unconfirmed disease is common in TB-exposed children.

117 ) and five (24%) had a partial response (one unconfirmed); eight (38%) patients had stable disease an

118 w testing other gMST predictions that remain unconfirmed empirically, such as conduit coalescence rat

119 ed (A-CD, n = 101; A-ID, n = 103; B, n = 44; unconfirmed FGF/FGFR status, n = 12).

120 ed genome-wide SNP associations and 89.8% of unconfirmed genome-wide indel associations.

121 de significant SNP associations and 97.6% of unconfirmed genome-wide significant indel associations.

122 This method removed 96.1% of unconfirmed genome-wide significant SNP associations and

123 pendent dataset, the method removed 90.2% of unconfirmed genome-wide SNP associations and 89.8% of un

124 Incidence rates of histologically unconfirmed HCC increased faster than those of confirmed

125 A popular but unconfirmed hypothesis to explain how the plasma is ener

126 A scan was classified unconfirmed if (68)Ga-DOTATOC PET/CT suggested a primary

127 CD was confirmed in 511 (25.9%) and was unconfirmed in 1391 (70.5%) patients; 14 patients were d

128 outcome in a Russian clinical trial that was unconfirmed in a replication trial in the United States.

129 in five patients (13.5%), complete response unconfirmed in three (8%), and partial response in 12 (3

130 ndependently confirmed in eight studies, but unconfirmed in two others, resulting in continued disput

131 e underlying proteolytic mechanism(s) remain unconfirmed in vivo.

132 jective response rate was 26% (confirmed and unconfirmed) in the 47 patients with measurable disease,

133 ber of treatments for malaria (confirmed and unconfirmed) in these older age groups was reduced by 29

134 Seven previously unconfirmed individuals tested positive for anti-MERS-Co

135 had not been infected with SARS-CoV-2 or had unconfirmed infection (-0.23 SD [95% confidence interval

136 globulin M antibody negative) and those with unconfirmed infection.

137 All suspected, confirmed or unconfirmed infections were considered "cases", and all

138 ortion at up to 42 days of gestation with an unconfirmed intrauterine pregnancy on ultrasound examina

139 analysis retrospectively provided previously unconfirmed links to environmental sources for clinical

140 nsoring, which results from having to censor unconfirmed locally determined progressions.

141 A promising, though unconfirmed mechanism for the observed quenching is ener

142 e immunophenotypic and recently proposed but unconfirmed molecular biomarkers in Sezary syndrome were

143 ritize and experimentally test a set of rare unconfirmed mutations in the epidermal growth factor rec

144 LL patient had a CR, one FL patient had a CR unconfirmed, one diffuse large B-cell lymphoma patient h

145 ll response rate consisting of patients with unconfirmed or confirmed response (u/cORR) of 52.5% (21/

146 ponse [complete or partial] vs no response), unconfirmed or confirmed.

147 urative intent, but many of these claims are unconfirmed or conflicting.

148 o have WNV infection, and the remainder were unconfirmed or determined to have false-positive results

149 Evidence of clinical activity (conventional, unconfirmed, or immune-related response or stable diseas

150 alth (NIH) case classification of Confirmed, Unconfirmed, or Unlikely TB.

151 Children were categorized as confirmed, unconfirmed, or unlikely tuberculosis according to NIH c

152 d clinical case definitions as "confirmed," "unconfirmed," or "unlikely" TB.

153 The unconfirmed ORR in 21 evaluable patients was 33% (7 of 2

154 the relatedness of which would have remained unconfirmed otherwise.

155 rnalization 5 (VRN5), which contains several unconfirmed partial RDs.

156 d one durable complete response (CR) and one unconfirmed partial response (PR) in two patients with E

157 was 18% (95% CI, 6.1 to 36.9); there was one unconfirmed partial response (PR).

158 nfirmed partial response in 14 (32%), and an unconfirmed partial response in nine (20%).

159 firmed partial response in six patients, and unconfirmed partial response in one patient.

160 An additional 31 (50%) had an unconfirmed partial response or stable disease as best r

161 o had received previous BRAF inhibition, one unconfirmed partial response was recorded.

162 lterations, four confirmed responses and one unconfirmed partial response were observed in patients w

163 le-agent antitumor activity were observed: 1 unconfirmed partial response with a time to progression

164 , eight confirmed partial responses, and one unconfirmed partial response) were observed with adavose

165 observed one (7.7%) confirmed and one (7.7%) unconfirmed partial response, 5 patients had stable dise

166 23 confirmed partial responses (51.1%), two unconfirmed partial responses (4.4%), 14 patients with s

167 (43%) had stable disease (four of these were unconfirmed partial responses), 36 (47%) had progressive

168 plete response, three partial responses, two unconfirmed partial responses, and 22 (30%) patients rem

169 Two further patients had unconfirmed partial responses.

170 ally sterile sites, suggesting potential but unconfirmed pathogenic relevance.

171 ification confirmation or lack thereof of an unconfirmed peak by comparison with a shape library of s

172 ty was observed for studies of patients with unconfirmed penicillin allergy who had been exposed to p

173 reveals approximately 500 new or previously unconfirmed plant mitochondrial proteins and outlines a

174 The questionable relevance of unconfirmed positive stool antigen CIDT results was supp

175 (19%) children with one sample, 70 (4%) were unconfirmed positive.

176 ee confirmed partial responses (PRs) and one unconfirmed PR for an overall response probability of 9%

177 ), 34 (52%) stable disease (SD), including 1 unconfirmed PR, and 27 (41%) progressive disease.

178 nd that the data contradict the authors' own unconfirmed previous results.

179 es potentially due to sequence divergence or unconfirmed protein expression levels.

180 There was one confirmed PR and two unconfirmed PRs.

181 rifampicin resistant in 6 [7%] ), 157 (54%), unconfirmed pulmonary tuberculosis, and 44 (15%), unlike

182 ed quality), III (promising quality), or IV (unconfirmed quality).

183 ositive, false-positive, false-negative, and unconfirmed rates for unknown primary tumor were 38%, 7%

184 lue for syphilis associated with an isolated unconfirmed reactive treponemal chemiluminescence assay

185 The remaining 88 patients (68%) had unconfirmed resistance on repeat Ultra.

186 se preclinical data and the phase I clinical unconfirmed response in a patient with KRAS-mutant spind

187 and 74% (95% CI, 64%-82%) for confirmed and unconfirmed response, respectively.

188 ous solid tumours, with partial confirmed or unconfirmed responses in four (8%) of 53 patients; 30 (5

189 sampled for DNA analysis due to molecularly unconfirmed retinal dystrophy and who were subsequently

190 given of patients with fatal, serologically unconfirmed RMSF for whom a diagnosis of RMSF was establ

191 The associations were stronger for unconfirmed self-reported events than end points that we

192 d of all confirmed cases (n = 18) but not in unconfirmed seropositive individuals (n = 8).

193 detected in the extravascular dermis of all unconfirmed seropositive individuals and all confirmed c

194 At enrollment, 11 seronegative, 8 unconfirmed seropositive, and 18 confirmed seropositive

195 ata on all subjects for whom vital status is unconfirmed should be sent to the SSA.

196 We also detect an unconfirmed signal with a period of ~50 days, which coul

197 variants in the ALS gene panel currently of unconfirmed significance after removing non-specific or

198 in laboratory experiments, SMRI has remained unconfirmed since its proposal, despite its astrophysica

199 irmed TB (microbiologic confirmation on IS), Unconfirmed TB (clinical diagnosis only), or Unlikely TB

200 ed as having microbiologically confirmed TB, unconfirmed TB (clinically diagnosed), or unlikely TB.

201 ositive Xpert Ultra and/or MGIT culture) and Unconfirmed TB (requiring two of TB exposure, compatible

202 hildren with bacteriologically confirmed and unconfirmed TB compared to children with unlikely TB (p

203 firmed TB), and composite (CRS, Confirmed or Unconfirmed TB vs Unlikely TB) reference standards compa

204 Moreover, children with unconfirmed TB with X-rays compatible with TB showed dif

205 Asymptomatic TB was defined as Confirmed or Unconfirmed TB without reported symptoms.

206 biological (MRS, Confirmed TB vs Unlikely or Unconfirmed TB), and composite (CRS, Confirmed or Unconf

207 reference standard (CRS, TB if Confirmed or Unconfirmed TB).

208 eriologically confirmed TB, 52 children with unconfirmed TB, and 4 children with unlikely TB.

209 Among children with either Confirmed or Unconfirmed TB, PCR on two oral swabs per child was 31%

210 Although unconfirmed, the data suggest that genetic associations

211 While the merit of this assumption remains unconfirmed, the model reported here offers a framework

212 Alternatively, consistent with a previously unconfirmed third hypothesis, the mycosamine sugar is st

213 med primary brain tumors (and a possible but unconfirmed third) were found, demonstrating a prevalenc

214 tuberculosis, 672 (35.6%) were classified as unconfirmed tuberculosis (clinically diagnosed, microbio

215 as microbiologically confirmed tuberculosis, unconfirmed tuberculosis (receipt of tuberculosis treatm

216 sis cases and 85% (39 [85%] of 46, 71-94) of unconfirmed tuberculosis cases diagnosed by non-microbio

217 composite reference standard (confirmed and unconfirmed tuberculosis versus unlikely tuberculosis) w

218 in vaccinated SOT recipients versus SOT with unconfirmed vaccination status (UVS) using multivariable

219 Complete remission (CR)/CR unconfirmed was achieved in 72 of 99 patients (72.7%) an

220 A designation of complete response/unconfirmed was adopted to include patients with a great

221 ber of treatments for malaria (confirmed and unconfirmed) was observed in children.

222 The ORR was 28% (7.5% CR/CR unconfirmed) with rapid time to response (median, 2.2 mo

223 Unconfirmed work has once more indicated that a viral in